BNBX Stock: BNB Plus Corp. Stock Price, Analysis & Insights
Get live bnbx stock price $1.23, comprehensive BNB Plus Corp. stock analysis, charts, news, and expert forecast. Real-time bnbx stock data and investment insights.
Loading chart...
Company Overview
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Company Information
- CEO
- Clay D. Shorrock
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 46
Contact Information
- Website
- https://www.bnbx.io
- Address
- 50 Health Sciences Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.17) may provide portfolio stability
Business Model & Strategy
BNB Plus Corp. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Clay D. Shorrock, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
BNB Plus Corp. competes in the Biotechnology within the broader Healthcare. With 1.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, BNB Plus Corp. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating BNB Plus Corp. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BNB Plus Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for BNB Plus Corp.
- ⚠Investors should consider how BNB Plus Corp. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.59M
P/E Ratio
-0.01
Beta
0.17
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.59M market capitalization
- Trading Volume: 319.89K shares traded today
- Price Range: 52-week range of $1.16 - $187.50
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for BNB Plus Corp.
BNB Plus Corp. (BNBX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 1.59M, the company represents a significant player in its market. The stock is currently trading at $1.23 with a negativedaily change of 20.13%.
The company's 46 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.01, beta of 0.17, and 52-week price range from $1.16 to $187.50when evaluating investment opportunities.
Why Invest in BNB Plus Corp.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Clay D. Shorrock
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.